You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API paclitaxel


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing paclitaxel

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Teva Pharmaceuticals Inc PACLITAXEL paclitaxel 0480-3290 ALBUMIN HUMAN
Teva Pharmaceuticals Inc PACLITAXEL paclitaxel 0480-3290 SODIUM CHLORIDE
American Regent Inc PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND paclitaxel 0517-4300 ALBUMIN HUMAN
American Regent Inc PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND paclitaxel 0517-4300 HYDROCHLORIC ACID
American Regent Inc PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND paclitaxel 0517-4300 SODIUM HYDROXIDE
TWi Pharmaceuticals Inc PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) paclitaxel 24979-710 ALBUMIN HUMAN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing paclitaxel

Company Ingredient NDC Excipient
Teva Parenteral Medicines Inc paclitaxel 0703-3213 ALCOHOL
Teva Parenteral Medicines Inc paclitaxel 0703-3213 ANHYDROUS CITRIC ACID
Teva Parenteral Medicines Inc paclitaxel 0703-3213 POLYOXYL 35 CASTOR OIL
Teva Parenteral Medicines Inc paclitaxel 0703-4764 ALCOHOL
Teva Parenteral Medicines Inc paclitaxel 0703-4764 ANHYDROUS CITRIC ACID
Teva Parenteral Medicines Inc paclitaxel 0703-4764 POLYOXYL 35 CASTOR OIL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for paclitaxel

Excipient focus: ALBUMIN HUMAN

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CASTOR OIL

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: POLYOXYL 35 CASTOR OIL

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group